देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
METFORMIN HYDROCHLORIDE
QD PHARMACEUTICALS ULC
A10BA02
METFORMIN
850MG
TABLET
METFORMIN HYDROCHLORIDE 850MG
ORAL
100/500
Prescription
BIGUANIDES
Active ingredient group (AIG) number: 0101773002; AHFS:
CANCELLED POST MARKET
2015-08-21
_ _ _Product Monograph – Q-Metformin _ _Page 1 _ PRODUCT MONOGRAPH PR Q-METFORMIN (METFORMIN HYDROCHLORIDE) TABLETS 500 AND 850 MG BP THERAPEUTIC CLASSIFICATION ORAL ANTIHYPERGLYCEMIC AGENT QD Pharmaceuticals ULC 85 Advance Road Etobicoke, ON Canada M8Z 2S6 Control No.: 147693 DATE OF PREPARATION: June 8, 2011 _ _ _Product Monograph –Q-Metformin _ _Page 2_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION........................................................ 3 SUMMARY PRODUCT INFORMATION ....................................................................... 3 INDICATIONS AND CLINICAL USE............................................................................. 3 CONTRAINDICATIONS .................................................................................................. 3 WARNINGS AND PRECAUTIONS................................................................................. 4 ADVERSE REACTIONS................................................................................................. 10 DRUG INTERACTIONS ................................................................................................. 11 DOSAGE AND ADMINISTRATION............................................................................. 14 OVERDOSAGE ............................................................................................................... 14 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 15 STORAGE AND STABILITY......................................................................................... 15 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................ 16 PART II: SCIENTIFIC INFORMATION ............................................................................... 17 PHARMACEUTICAL INFORMATION......................................................................... 17 CLINICAL TRIALS......................................................................................................... 18 DETAILED PHARMACOLOGY.. पूरा दस्तावेज़ पढ़ें